SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $21,000 | -16.0% | 156 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $25,000 | +127.3% | 156 | +40.5% | 0.00% | +100.0% |
| Q1 2020 | $11,000 | -21.4% | 111 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $14,000 | +75.0% | 111 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $8,000 | -65.2% | 111 | -28.8% | 0.00% | -60.0% |
| Q2 2019 | $23,000 | +53.3% | 156 | +23.8% | 0.01% | +66.7% |
| Q1 2019 | $15,000 | -21.1% | 126 | -28.4% | 0.00% | -40.0% |
| Q4 2018 | $19,000 | -26.9% | 176 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $26,000 | -3.7% | 176 | -16.6% | 0.01% | 0.0% |
| Q2 2018 | $27,000 | – | 211 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |